219 related articles for article (PubMed ID: 15122056)
1. Oxidative stress influences CC-chemokine levels in hemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Nephron Physiol; 2004; 96(4):p105-12. PubMed ID: 15122056
[TBL] [Abstract][Full Text] [Related]
2. Circulating beta-chemokines and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system in hemodialyzed patients--role of oxidative stress.
Pawlak K; Pawlak D; Mysliwiec M
Cytokine; 2005 Jul; 31(1):18-24. PubMed ID: 15896974
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis intensified oxidative stress, MIP-1beta and RANTES plasma levels in uraemic patients.
Pawlak K; Pawlak D; Mysliwiec M
Cytokine; 2004 Dec; 28(6):197-204. PubMed ID: 15566948
[TBL] [Abstract][Full Text] [Related]
4. [Method of dialysis therapy and selected markers of oxidative stress and endothelial injury in patients with chronic renal failure].
Pawlak K; Pawlak D; Myśliwiec M
Pol Arch Med Wewn; 2005 Jan; 113(1):21-6. PubMed ID: 16130597
[TBL] [Abstract][Full Text] [Related]
5. Possible new role of monocyte chemoattractant protein-1 in hemodialysis patients with cardiovascular disease.
Pawlak K; Pawlak D; Mysliwiec M
Am J Nephrol; 2004; 24(6):635-40. PubMed ID: 15627719
[TBL] [Abstract][Full Text] [Related]
6. Relations between oxidative stress, hepatocyte growth factor, and liver disease in hemodialysis patients.
Borawski J; Pawlak K; Naumnik B; Myśliwiec M
Ren Fail; 2002 Nov; 24(6):825-37. PubMed ID: 12472204
[TBL] [Abstract][Full Text] [Related]
7. Inflammation but not oxidative stress is associated with beta-chemokine levels and prevalence of cardiovascular disease in uraemic patients.
Pawlak K; Pawlak D; Myśliwiec M
Cytokine; 2006 Sep; 35(5-6):258-62. PubMed ID: 17070067
[TBL] [Abstract][Full Text] [Related]
8. Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease.
Pawlak K; Pawlak D; Mysliwiec M
Clin Biochem; 2007 Jan; 40(1-2):81-5. PubMed ID: 17046733
[TBL] [Abstract][Full Text] [Related]
9. Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Atherosclerosis; 2007 Jan; 190(1):199-204. PubMed ID: 16510149
[TBL] [Abstract][Full Text] [Related]
10. Carotid atherosclerosis is associated with enhanced beta-chemokine levels in patients on continuous ambulatory peritoneal dialysis.
Pawlak K; Pawlak D; Brzosko S; Mysliwiec M
Atherosclerosis; 2006 May; 186(1):146-51. PubMed ID: 16099464
[TBL] [Abstract][Full Text] [Related]
11. Possible association between circulating vascular endothelial growth factor and oxidative stress markers in hemodialysis patients.
Pawlak K; Pawlak D; Myśliwiec M
Med Sci Monit; 2006 Apr; 12(4):CR181-5. PubMed ID: 16572054
[TBL] [Abstract][Full Text] [Related]
12. Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease.
Pawlak K; Pawlak D; Mysliwiec M
Clin Biochem; 2005 Aug; 38(8):700-5. PubMed ID: 15963971
[TBL] [Abstract][Full Text] [Related]
13. Long-term erythropoietin therapy decreases CC-chemokine levels and intima-media thickness in hemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Am J Nephrol; 2006; 26(5):497-502. PubMed ID: 17119331
[TBL] [Abstract][Full Text] [Related]
14. Relationship between oxidative stress and extrinsic coagulation pathway in haemodialyzed patients.
Pawlak K; Borawski J; Naumnik B; Mysliwiec M
Thromb Res; 2003 Mar; 109(5-6):247-51. PubMed ID: 12818246
[TBL] [Abstract][Full Text] [Related]
15. oxLDL - the molecule linking hypercoagulability with the presence of cardiovascular disease in hemodialyzed uraemic patients.
Pawlak K; Mysliwiec M; Pawlak D
Thromb Res; 2014 Sep; 134(3):711-6. PubMed ID: 25065558
[TBL] [Abstract][Full Text] [Related]
16. Extrinsic coagulation pathway activation and metalloproteinase-2/TIMPs system are related to oxidative stress and atherosclerosis in hemodialysis patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Haemost; 2004 Sep; 92(3):646-53. PubMed ID: 15351863
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2007; 120(6):871-6. PubMed ID: 17331567
[TBL] [Abstract][Full Text] [Related]
18. Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio - are they real oxidative stress markers in dialyzed patients?
Pawlak K; Mysliwiec M; Pawlak D
Life Sci; 2013 Mar; 92(4-5):253-8. PubMed ID: 23295961
[TBL] [Abstract][Full Text] [Related]
19. Reduced plasma zinc levels, lipid peroxidation, and inflammation biomarkers levels in hemodialysis patients: implications to cardiovascular mortality.
Lobo JC; Stockler-Pinto MB; Farage NE; Faulin Tdo E; Abdalla DS; Torres JP; Velarde LG; Mafra D
Ren Fail; 2013; 35(5):680-5. PubMed ID: 23650973
[TBL] [Abstract][Full Text] [Related]
20. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis.
Filiopoulos V; Hadjiyannakos D; Takouli L; Metaxaki P; Sideris V; Vlassopoulos D
Int J Artif Organs; 2009 Dec; 32(12):872-82. PubMed ID: 20037892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
